ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment OptionsJean‐Jacques Kiladjian, Christoph Klade, Francisca Ferrer‐Marín et al.|Blood|2024Cited by 0